APO Research
Talk to an analyst

APO RESEARCH · REPORT

Penicillin Intermediate

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Penicillin Intermediate Industry Growth and Trends Forecast to 2032

28 December 2025126 pages

Choose your research edition.

Industry ResearchPenicillin Intermediate Industry Research Report 2026149 pages · $2,950 USDIndustry Growth & TrendsGlobal Penicillin Intermediate Industry Growth and Trends Forecast to 2032126 pages · $3,450 USDMarket StructureGlobal Penicillin Intermediate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Penicillin Intermediate Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Penicillin Intermediate Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global Penicillin Intermediate market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Penicillin Intermediate is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Penicillin Intermediate is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Penicillin Intermediate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Penicillin Intermediate include Sinopharm Weiqida Pharmaceutical, Kasugamycin hydrochloride, Shanghai Hongsheng, Apeloa Pharmaceutical, The United Laboratories International Holdings Limited, Sichuan Kelun Pharmaceutical, Jiangxi Huabang, North China Pharmaceutical Company and Henan Huaxing, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Penicillin Intermediate market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Penicillin Intermediate market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Penicillin Intermediate market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Penicillin Intermediate.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Penicillin Intermediate market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Penicillin Intermediate Market by Company

Sinopharm Weiqida Pharmaceutical

Kasugamycin hydrochloride

Shanghai Hongsheng

Apeloa Pharmaceutical

The United Laboratories International Holdings Limited

Sichuan Kelun Pharmaceutical

Jiangxi Huabang

North China Pharmaceutical Company

Henan Huaxing

Harbin Pharmaceutical Group

Shanghai Shyndec Pharmaceutical

Fuan Pharmaceutical group

Yili Chuanning Biotechnology

Changzhou RedSun

Centrient Pharmaceuticals

XINXIANG BEST PHARMACEUTICAL

United Laboratories

TUL

Sinopharm Weiqida Pharmaceutical

Sichuan Huaxin

Qilu Tianhe Pharma

Novartis Sandoz Anti-Infectives

LKPC

Kelun

Jiangxi Fushine Pharmaceutical

Huayao Group

Hayao

E-Cspc

CSPC Zhongrun

Penicillin Intermediate Segment by Type

6-APA

Penicillin G and V Potassium Salt

Others

Penicillin Intermediate Segment by Application

Penicillin Antibiotics

Cephalosporin Antibiotics

Penicillin Intermediate Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Penicillin Intermediate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Penicillin Intermediate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Penicillin Intermediate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Penicillin Intermediate manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Penicillin Intermediate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 6-APA Table 2. Major Company of Penicillin G and V Potassium Salt Table 3. Major Company of Others Table 4. Global Penicillin Intermediate Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Penicillin Intermediate Sales by Type (2021-2026) & (Tons) Table 6. Global Penicillin Intermediate Sales Market Share in Volume by Type (2021-2026) Table 7. Global Penicillin Intermediate Sales by Type (2021-2026) & (US$ Million) Table 8. Global Penicillin Intermediate Sales Market Share in Value by Type (2021-2026) Table 9. Global Penicillin Intermediate Price by Type (2021-2026) & (US$/Kg) Table 10. Global Penicillin Intermediate Sales by Type (2027-2032) & (Tons) Table 11. Global Penicillin Intermediate Sales Market Share in Volume by Type (2027-2032) Table 12. Global Penicillin Intermediate Sales by Type (2027-2032) & (US$ Million) Table 13. Global Penicillin Intermediate Sales Market Share in Value by Type (2027-2032) Table 14. Global Penicillin Intermediate Price by Type (2027-2032) & (US$/Kg) Table 15. North America Penicillin Intermediate Sales by Type (2021-2026) & (Tons) Table 16. North America Penicillin Intermediate Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Penicillin Intermediate Sales by Type (2021-2026) & (Tons) Table 18. Europe Penicillin Intermediate Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Penicillin Intermediate Sales by Type (2021-2026) & (Tons) Table 20. Asia-Pacific Penicillin Intermediate Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Penicillin Intermediate Sales by Type (2021-2026) & (Tons) Table 22. Latin America Penicillin Intermediate Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Penicillin Intermediate Sales by Type (2021-2026) & (Tons) Table 24. Middle East and Africa Penicillin Intermediate Sales by Type (2021-2026) & (US$ Million) Table 25. Penicillin Intermediate Industry Trends Table 26. Penicillin Intermediate Industry Drivers Table 27. Penicillin Intermediate Industry Opportunities and Challenges Table 28. Penicillin Intermediate Industry Restraints Table 29. Global Penicillin Intermediate Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Penicillin Intermediate Revenue Market Share by Company (2021-2026) Table 31. Global Penicillin Intermediate Sales by Company (2021-2026) & (Tons) Table 32. Global Penicillin Intermediate Sales Share by Company (2021-2026) Table 33. Global Penicillin Intermediate Market Price by Company (2021-2026) & (US$/Kg) Table 34. Global Penicillin Intermediate Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Penicillin Intermediate Major Company Production Sites and Headquarters Table 36. Global Penicillin Intermediate Company, Product Type & Application Table 37. Global Penicillin Intermediate Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Penicillin Intermediate by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Penicillin Intermediate Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Penicillin Intermediate Sales by Region (2021-2026) & (Tons) Table 42. Global Penicillin Intermediate Sales Market Share in Volume by Region (2021-2026) Table 43. Global Penicillin Intermediate Sales by Region (2021-2026) & (US$ Million) Table 44. Global Penicillin Intermediate Sales Market Share in Value by Region (2021-2026) Table 45. Global Penicillin Intermediate Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 46. Global Penicillin Intermediate Sales by Region (2027-2032) & (Tons) Table 47. Global Penicillin Intermediate Sales Market Share in Volume by Region (2027-2032) Table 48. Global Penicillin Intermediate Sales by Region (2027-2032) & (US$ Million) Table 49. Global Penicillin Intermediate Sales Market Share in Value by Region (2027-2032) Table 50. Global Penicillin Intermediate Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2027-2032) Table 51. Global Penicillin Intermediate Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Penicillin Intermediate Sales by Application (2021-2026) & (Tons) Table 53. Global Penicillin Intermediate Sales Market Share in Volume by Application (2021-2026) Table 54. Global Penicillin Intermediate Sales by Application (2021-2026) & (US$ Million) Table 55. Global Penicillin Intermediate Sales Market Share in Value by Application (2021-2026) Table 56. Global Penicillin Intermediate Price by Application (2021-2026) & (US$/Kg) Table 57. Global Penicillin Intermediate Sales by Application (2027-2032) & (Tons) Table 58. Global Penicillin Intermediate Sales Market Share in Volume by Application (2027-2032) Table 59. Global Penicillin Intermediate Sales by Application (2027-2032) & (US$ Million) Table 60. Global Penicillin Intermediate Sales Market Share in Value by Application (2027-2032) Table 61. Global Penicillin Intermediate Price by Application (2027-2032) & (US$/Kg) Table 62. North America Penicillin Intermediate Sales by Application (2021-2026) & (Tons) Table 63. North America Penicillin Intermediate Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Penicillin Intermediate Sales by Application (2021-2026) & (Tons) Table 65. Europe Penicillin Intermediate Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Penicillin Intermediate Sales by Application (2021-2026) & (Tons) Table 67. Asia-Pacific Penicillin Intermediate Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Penicillin Intermediate Sales by Application (2021-2026) & (Tons) Table 69. Latin America Penicillin Intermediate Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Penicillin Intermediate Sales by Application (2021-2026) & (Tons) Table 71. Middle East and Africa Penicillin Intermediate Sales by Application (2021-2026) & (US$ Million) Table 72. Sinopharm Weiqida Pharmaceutical Company Information Table 73. Sinopharm Weiqida Pharmaceutical Business Overview Table 74. Sinopharm Weiqida Pharmaceutical Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 75. Sinopharm Weiqida Pharmaceutical Penicillin Intermediate Product Portfolio Table 76. Sinopharm Weiqida Pharmaceutical Recent Development Table 77. Kasugamycin hydrochloride Company Information Table 78. Kasugamycin hydrochloride Business Overview Table 79. Kasugamycin hydrochloride Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 80. Kasugamycin hydrochloride Penicillin Intermediate Product Portfolio Table 81. Kasugamycin hydrochloride Recent Development Table 82. Shanghai Hongsheng Company Information Table 83. Shanghai Hongsheng Business Overview Table 84. Shanghai Hongsheng Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 85. Shanghai Hongsheng Penicillin Intermediate Product Portfolio Table 86. Shanghai Hongsheng Recent Development Table 87. Apeloa Pharmaceutical Company Information Table 88. Apeloa Pharmaceutical Business Overview Table 89. Apeloa Pharmaceutical Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 90. Apeloa Pharmaceutical Penicillin Intermediate Product Portfolio Table 91. Apeloa Pharmaceutical Recent Development Table 92. The United Laboratories International Holdings Limited Company Information Table 93. The United Laboratories International Holdings Limited Business Overview Table 94. The United Laboratories International Holdings Limited Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 95. The United Laboratories International Holdings Limited Penicillin Intermediate Product Portfolio Table 96. The United Laboratories International Holdings Limited Recent Development Table 97. Sichuan Kelun Pharmaceutical Company Information Table 98. Sichuan Kelun Pharmaceutical Business Overview Table 99. Sichuan Kelun Pharmaceutical Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 100. Sichuan Kelun Pharmaceutical Penicillin Intermediate Product Portfolio Table 101. Sichuan Kelun Pharmaceutical Recent Development Table 102. Jiangxi Huabang Company Information Table 103. Jiangxi Huabang Business Overview Table 104. Jiangxi Huabang Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 105. Jiangxi Huabang Penicillin Intermediate Product Portfolio Table 106. Jiangxi Huabang Recent Development Table 107. North China Pharmaceutical Company Company Information Table 108. North China Pharmaceutical Company Business Overview Table 109. North China Pharmaceutical Company Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 110. North China Pharmaceutical Company Penicillin Intermediate Product Portfolio Table 111. North China Pharmaceutical Company Recent Development Table 112. Henan Huaxing Company Information Table 113. Henan Huaxing Business Overview Table 114. Henan Huaxing Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 115. Henan Huaxing Penicillin Intermediate Product Portfolio Table 116. Henan Huaxing Recent Development Table 117. Harbin Pharmaceutical Group Company Information Table 118. Harbin Pharmaceutical Group Business Overview Table 119. Harbin Pharmaceutical Group Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 120. Harbin Pharmaceutical Group Penicillin Intermediate Product Portfolio Table 121. Harbin Pharmaceutical Group Recent Development Table 122. Shanghai Shyndec Pharmaceutical Company Information Table 123. Shanghai Shyndec Pharmaceutical Business Overview Table 124. Shanghai Shyndec Pharmaceutical Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 125. Shanghai Shyndec Pharmaceutical Penicillin Intermediate Product Portfolio Table 126. Shanghai Shyndec Pharmaceutical Recent Development Table 127. Fuan Pharmaceutical group Company Information Table 128. Fuan Pharmaceutical group Business Overview Table 129. Fuan Pharmaceutical group Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 130. Fuan Pharmaceutical group Penicillin Intermediate Product Portfolio Table 131. Fuan Pharmaceutical group Recent Development Table 132. Yili Chuanning Biotechnology Company Information Table 133. Yili Chuanning Biotechnology Business Overview Table 134. Yili Chuanning Biotechnology Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 135. Yili Chuanning Biotechnology Penicillin Intermediate Product Portfolio Table 136. Yili Chuanning Biotechnology Recent Development Table 137. Changzhou RedSun Company Information Table 138. Changzhou RedSun Business Overview Table 139. Changzhou RedSun Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 140. Changzhou RedSun Penicillin Intermediate Product Portfolio Table 141. Changzhou RedSun Recent Development Table 142. Centrient Pharmaceuticals Company Information Table 143. Centrient Pharmaceuticals Business Overview Table 144. Centrient Pharmaceuticals Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 145. Centrient Pharmaceuticals Penicillin Intermediate Product Portfolio Table 146. Centrient Pharmaceuticals Recent Development Table 147. XINXIANG BEST PHARMACEUTICAL Company Information Table 148. XINXIANG BEST PHARMACEUTICAL Business Overview Table 149. XINXIANG BEST PHARMACEUTICAL Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 150. XINXIANG BEST PHARMACEUTICAL Penicillin Intermediate Product Portfolio Table 151. XINXIANG BEST PHARMACEUTICAL Recent Development Table 152. United Laboratories Company Information Table 153. United Laboratories Business Overview Table 154. United Laboratories Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 155. United Laboratories Penicillin Intermediate Product Portfolio Table 156. United Laboratories Recent Development Table 157. TUL Company Information Table 158. TUL Business Overview Table 159. TUL Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 160. TUL Penicillin Intermediate Product Portfolio Table 161. TUL Recent Development Table 162. Sinopharm Weiqida Pharmaceutical Company Information Table 163. Sinopharm Weiqida Pharmaceutical Business Overview Table 164. Sinopharm Weiqida Pharmaceutical Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 165. Sinopharm Weiqida Pharmaceutical Penicillin Intermediate Product Portfolio Table 166. Sinopharm Weiqida Pharmaceutical Recent Development Table 167. Sichuan Huaxin Company Information Table 168. Sichuan Huaxin Business Overview Table 169. Sichuan Huaxin Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 170. Sichuan Huaxin Penicillin Intermediate Product Portfolio Table 171. Sichuan Huaxin Recent Development Table 172. Qilu Tianhe Pharma Company Information Table 173. Qilu Tianhe Pharma Business Overview Table 174. Qilu Tianhe Pharma Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 175. Qilu Tianhe Pharma Penicillin Intermediate Product Portfolio Table 176. Qilu Tianhe Pharma Recent Development Table 177. Novartis Sandoz Anti-Infectives Company Information Table 178. Novartis Sandoz Anti-Infectives Business Overview Table 179. Novartis Sandoz Anti-Infectives Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 180. Novartis Sandoz Anti-Infectives Penicillin Intermediate Product Portfolio Table 181. Novartis Sandoz Anti-Infectives Recent Development Table 182. LKPC Company Information Table 183. LKPC Business Overview Table 184. LKPC Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 185. LKPC Penicillin Intermediate Product Portfolio Table 186. LKPC Recent Development Table 187. Kelun Company Information Table 188. Kelun Business Overview Table 189. Kelun Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 190. Kelun Penicillin Intermediate Product Portfolio Table 191. Kelun Recent Development Table 192. Jiangxi Fushine Pharmaceutical Company Information Table 193. Jiangxi Fushine Pharmaceutical Business Overview Table 194. Jiangxi Fushine Pharmaceutical Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 195. Jiangxi Fushine Pharmaceutical Penicillin Intermediate Product Portfolio Table 196. Jiangxi Fushine Pharmaceutical Recent Development Table 197. Huayao Group Company Information Table 198. Huayao Group Business Overview Table 199. Huayao Group Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 200. Huayao Group Penicillin Intermediate Product Portfolio Table 201. Huayao Group Recent Development Table 202. Hayao Company Information Table 203. Hayao Business Overview Table 204. Hayao Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 205. Hayao Penicillin Intermediate Product Portfolio Table 206. Hayao Recent Development Table 207. E-Cspc Company Information Table 208. E-Cspc Business Overview Table 209. E-Cspc Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 210. E-Cspc Penicillin Intermediate Product Portfolio Table 211. E-Cspc Recent Development Table 212. CSPC Zhongrun Company Information Table 213. CSPC Zhongrun Business Overview Table 214. CSPC Zhongrun Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 215. CSPC Zhongrun Penicillin Intermediate Product Portfolio Table 216. CSPC Zhongrun Recent Development Table 217. North America Penicillin Intermediate Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 218. North America Penicillin Intermediate Sales by Country (2021-2026) & (Tons) Table 219. North America Penicillin Intermediate Sales Market Share by Country (2021-2026) Table 220. North America Penicillin Intermediate Sales Forecast by Country (2027-2032) & (Tons) Table 221. North America Penicillin Intermediate Sales Market Share Forecast by Country (2027-2032) Table 222. North America Penicillin Intermediate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 223. North America Penicillin Intermediate Market Size by Country (2021-2026) & (US$ Million) Table 224. North America Penicillin Intermediate Market Share by Country (2021-2026) Table 225. North America Penicillin Intermediate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 226. North America Penicillin Intermediate Market Share Forecast by Country (2027-2032) Table 227. Europe Penicillin Intermediate Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 228. Europe Penicillin Intermediate Sales by Country (2021-2026) & (Tons) Table 229. Europe Penicillin Intermediate Sales Market Share by Country (2021-2026) Table 230. Europe Penicillin Intermediate Sales Forecast by Country (2027-2032) & (Tons) Table 231. Europe Penicillin Intermediate Sales Market Share Forecast by Country (2027-2032) Table 232. Europe Penicillin Intermediate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 233. Europe Penicillin Intermediate Market Size by Country (2021-2026) & (US$ Million) Table 234. Europe Penicillin Intermediate Market Share by Country (2021-2026) Table 235. Europe Penicillin Intermediate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 236. Europe Penicillin Intermediate Market Share Forecast by Country (2027-2032) Table 237. Asia-Pacific Penicillin Intermediate Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 238. Asia-Pacific Penicillin Intermediate Sales by Country (2021-2026) & (Tons) Table 239. Asia-Pacific Penicillin Intermediate Sales Market Share by Country (2021-2026) Table 240. Asia-Pacific Penicillin Intermediate Sales Forecast by Country (2027-2032) & (Tons) Table 241. Asia-Pacific Penicillin Intermediate Sales Market Share Forecast by Country (2027-2032) Table 242. Asia-Pacific Penicillin Intermediate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 243. Asia-Pacific Penicillin Intermediate Market Size by Country (2021-2026) & (US$ Million) Table 244. Asia-Pacific Penicillin Intermediate Market Share by Country (2021-2026) Table 245. Asia-Pacific Penicillin Intermediate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 246. Asia-Pacific Penicillin Intermediate Market Share Forecast by Country (2027-2032) Table 247. Latin America Penicillin Intermediate Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 248. Latin America Penicillin Intermediate Sales by Country (2021-2026) & (Tons) Table 249. Latin America Penicillin Intermediate Sales Market Share by Country (2021-2026) Table 250. Latin America Penicillin Intermediate Sales Forecast by Country (2027-2032) & (Tons) Table 251. Latin America Penicillin Intermediate Sales Market Share Forecast by Country (2027-2032) Table 252. Latin America Penicillin Intermediate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 253. Latin America Penicillin Intermediate Market Size by Country (2021-2026) & (US$ Million) Table 254. Latin America Penicillin Intermediate Market Share by Country (2021-2026) Table 255. Latin America Penicillin Intermediate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 256. Latin America Penicillin Intermediate Market Share Forecast by Country (2027-2032) Table 257. Middle East and Africa Penicillin Intermediate Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 258. Middle East and Africa Penicillin Intermediate Sales by Country (2021-2026) & (Tons) Table 259. Middle East and Africa Penicillin Intermediate Sales Market Share by Country (2021-2026) Table 260. Middle East and Africa Penicillin Intermediate Sales Forecast by Country (2027-2032) & (Tons) Table 261. Middle East and Africa Penicillin Intermediate Sales Market Share Forecast by Country (2027-2032) Table 262. Middle East and Africa Penicillin Intermediate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 263. Middle East and Africa Penicillin Intermediate Market Size by Country (2021-2026) & (US$ Million) Table 264. Middle East and Africa Penicillin Intermediate Market Share by Country (2021-2026) Table 265. Middle East and Africa Penicillin Intermediate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 266. Middle East and Africa Penicillin Intermediate Market Share Forecast by Country (2027-2032) Table 267. Key Raw Materials Table 268. Raw Materials Key Suppliers Table 269. Penicillin Intermediate Distributors List Table 270. Penicillin Intermediate Customers List Table 271. Research Programs/Design for This Report Table 272. Authors List of This Report Table 273. Secondary Sources Table 274. Primary Sources List of Figures Figure 1. Penicillin Intermediate Image Figure 2. Global Penicillin Intermediate Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Penicillin Intermediate Market Size (2021-2032) & (US$ Million) Figure 4. Global Penicillin Intermediate Sales (2021-2032) & (Tons) Figure 5. 6-APA Image Figure 6. Global 6-APA Sales YoY Growth (2021-2032) & (Tons) Figure 7. Penicillin G and V Potassium Salt Image Figure 8. Global Penicillin G and V Potassium Salt Sales YoY Growth (2021-2032) & (Tons) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (Tons) Figure 11. Global Penicillin Intermediate Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Penicillin Intermediate Market Share by Type 2025 VS 2032 Figure 13. North America Penicillin Intermediate Sales Market Share in Volume by Type in 2025 Figure 14. North America Penicillin Intermediate Sales Market Share in Value by Type in 2025 Figure 15. Europe Penicillin Intermediate Sales Market Share in Volume by Type in 2025 Figure 16. Europe Penicillin Intermediate Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Penicillin Intermediate Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Penicillin Intermediate Sales Market Share in Value by Type in 2025 Figure 19. Latin America Penicillin Intermediate Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Penicillin Intermediate Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Penicillin Intermediate Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Penicillin Intermediate Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Penicillin Intermediate Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Penicillin Antibiotics Image Figure 26. Global Penicillin Antibiotics Sales YoY Growth (2021-2032) & (Tons) Figure 27. Cephalosporin Antibiotics Image Figure 28. Global Cephalosporin Antibiotics Sales YoY Growth (2021-2032) & (Tons) Figure 29. Global Penicillin Intermediate Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Penicillin Intermediate Market Share by Application 2025 VS 2032 Figure 31. North America Penicillin Intermediate Sales Market Share in Volume by Application in 2025 Figure 32. North America Penicillin Intermediate Sales Market Share in Value by Application in 2025 Figure 33. Europe Penicillin Intermediate Sales Market Share in Volume by Application in 2025 Figure 34. Europe Penicillin Intermediate Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Penicillin Intermediate Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Penicillin Intermediate Sales Market Share in Value by Application in 2025 Figure 37. Latin America Penicillin Intermediate Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Penicillin Intermediate Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Penicillin Intermediate Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Penicillin Intermediate Sales Market Share in Value by Application in 2025 Figure 41. North America Penicillin Intermediate Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 42. North America Penicillin Intermediate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Penicillin Intermediate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Penicillin Intermediate Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Penicillin Intermediate Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 46. Europe Penicillin Intermediate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Penicillin Intermediate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Penicillin Intermediate Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Penicillin Intermediate Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 50. Asia-Pacific Penicillin Intermediate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Penicillin Intermediate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Penicillin Intermediate Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Penicillin Intermediate Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 54. Latin America Penicillin Intermediate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Penicillin Intermediate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Penicillin Intermediate Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Penicillin Intermediate Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 58. Middle East and Africa Penicillin Intermediate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Penicillin Intermediate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Penicillin Intermediate Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Penicillin Intermediate Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Penicillin Intermediate Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 6-APA
  • Penicillin G and V Potassium Salt
  • Others
Applications
  • Penicillin Antibiotics
  • Cephalosporin Antibiotics
Companies covered
  • Sinopharm Weiqida Pharmaceutical
  • Kasugamycin hydrochloride
  • Shanghai Hongsheng
  • Apeloa Pharmaceutical
  • The United Laboratories International Holdings Limited
  • Sichuan Kelun Pharmaceutical
  • Jiangxi Huabang
  • North China Pharmaceutical Company
  • Henan Huaxing
  • Harbin Pharmaceutical Group
  • Shanghai Shyndec Pharmaceutical
  • Fuan Pharmaceutical group
  • Yili Chuanning Biotechnology
  • Changzhou RedSun
  • Centrient Pharmaceuticals
  • XINXIANG BEST PHARMACEUTICAL
  • United Laboratories
  • TUL
  • Sinopharm Weiqida Pharmaceutical
  • Sichuan Huaxin
  • Qilu Tianhe Pharma
  • Novartis Sandoz Anti-Infectives
  • LKPC
  • Kelun
  • Jiangxi Fushine Pharmaceutical
  • Huayao Group
  • Hayao
  • E-Cspc
  • CSPC Zhongrun

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Penicillin Intermediate Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Penicillin Intermediate Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Penicillin Intermediate Market by Type
  6. 1.3.1 6-APA
  7. 1.3.2 Penicillin G and V Potassium Salt
  8. 1.3.3 Others
  9. 1.4 Global Penicillin Intermediate Market Size by Type
  10. 1.4.1 Global Penicillin Intermediate Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Penicillin Intermediate Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Penicillin Intermediate Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Penicillin Intermediate Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Penicillin Intermediate Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Penicillin Intermediate Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Penicillin Intermediate Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Penicillin Intermediate Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Penicillin Intermediate Industry Trends
  2. 2.2 Penicillin Intermediate Industry Drivers
  3. 2.3 Penicillin Intermediate Industry Opportunities and Challenges
  4. 2.4 Penicillin Intermediate Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Penicillin Intermediate Revenue (2021-2026)
  2. 3.2 Global Top Players by Penicillin Intermediate Sales (2021-2026)
  3. 3.3 Global Top Players by Penicillin Intermediate Price (2021-2026)
  4. 3.4 Global Penicillin Intermediate Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Penicillin Intermediate Major Company Production Sites & Headquarters
  6. 3.6 Global Penicillin Intermediate Company, Product Type & Application
  7. 3.7 Global Penicillin Intermediate Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Penicillin Intermediate Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Penicillin Intermediate Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Penicillin Intermediate Tier 1, Tier 2, and Tier 3
4 Penicillin Intermediate Regional Status and Outlook
  1. 4.1 Global Penicillin Intermediate Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Penicillin Intermediate Historic Market Size by Region
  3. 4.2.1 Global Penicillin Intermediate Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Penicillin Intermediate Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Penicillin Intermediate Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Penicillin Intermediate Forecasted Market Size by Region
  7. 4.3.1 Global Penicillin Intermediate Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Penicillin Intermediate Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Penicillin Intermediate Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Penicillin Intermediate by Application
  1. 5.1 Penicillin Intermediate Market by Application
  2. 5.1.1 Penicillin Antibiotics
  3. 5.1.2 Cephalosporin Antibiotics
  4. 5.2 Global Penicillin Intermediate Market Size by Application
  5. 5.2.1 Global Penicillin Intermediate Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Penicillin Intermediate Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Penicillin Intermediate Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Penicillin Intermediate Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Penicillin Intermediate Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Penicillin Intermediate Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Penicillin Intermediate Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Penicillin Intermediate Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sinopharm Weiqida Pharmaceutical
  2. 6.1.1 Sinopharm Weiqida Pharmaceutical Company Information
  3. 6.1.2 Sinopharm Weiqida Pharmaceutical Business Overview
  4. 6.1.3 Sinopharm Weiqida Pharmaceutical Penicillin Intermediate Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sinopharm Weiqida Pharmaceutical Penicillin Intermediate Product Portfolio
  6. 6.1.5 Sinopharm Weiqida Pharmaceutical Recent Developments
  7. 6.2 Kasugamycin hydrochloride
  8. 6.2.1 Kasugamycin hydrochloride Company Information
  9. 6.2.2 Kasugamycin hydrochloride Business Overview
  10. 6.2.3 Kasugamycin hydrochloride Penicillin Intermediate Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Kasugamycin hydrochloride Penicillin Intermediate Product Portfolio
  12. 6.2.5 Kasugamycin hydrochloride Recent Developments
  13. 6.3 Shanghai Hongsheng
  14. 6.3.1 Shanghai Hongsheng Company Information
  15. 6.3.2 Shanghai Hongsheng Business Overview
  16. 6.3.3 Shanghai Hongsheng Penicillin Intermediate Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Shanghai Hongsheng Penicillin Intermediate Product Portfolio
  18. 6.3.5 Shanghai Hongsheng Recent Developments
  19. 6.4 Apeloa Pharmaceutical
  20. 6.4.1 Apeloa Pharmaceutical Company Information
  21. 6.4.2 Apeloa Pharmaceutical Business Overview
  22. 6.4.3 Apeloa Pharmaceutical Penicillin Intermediate Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Apeloa Pharmaceutical Penicillin Intermediate Product Portfolio
  24. 6.4.5 Apeloa Pharmaceutical Recent Developments
  25. 6.5 The United Laboratories International Holdings Limited
  26. 6.5.1 The United Laboratories International Holdings Limited Company Information
  27. 6.5.2 The United Laboratories International Holdings Limited Business Overview
  28. 6.5.3 The United Laboratories International Holdings Limited Penicillin Intermediate Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 The United Laboratories International Holdings Limited Penicillin Intermediate Product Portfolio
  30. 6.5.5 The United Laboratories International Holdings Limited Recent Developments
  31. 6.6 Sichuan Kelun Pharmaceutical
  32. 6.6.1 Sichuan Kelun Pharmaceutical Company Information
  33. 6.6.2 Sichuan Kelun Pharmaceutical Business Overview
  34. 6.6.3 Sichuan Kelun Pharmaceutical Penicillin Intermediate Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sichuan Kelun Pharmaceutical Penicillin Intermediate Product Portfolio
  36. 6.6.5 Sichuan Kelun Pharmaceutical Recent Developments
  37. 6.7 Jiangxi Huabang
  38. 6.7.1 Jiangxi Huabang Company Information
  39. 6.7.2 Jiangxi Huabang Business Overview
  40. 6.7.3 Jiangxi Huabang Penicillin Intermediate Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Jiangxi Huabang Penicillin Intermediate Product Portfolio
  42. 6.7.5 Jiangxi Huabang Recent Developments
  43. 6.8 North China Pharmaceutical Company
  44. 6.8.1 North China Pharmaceutical Company Company Information
  45. 6.8.2 North China Pharmaceutical Company Business Overview
  46. 6.8.3 North China Pharmaceutical Company Penicillin Intermediate Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 North China Pharmaceutical Company Penicillin Intermediate Product Portfolio
  48. 6.8.5 North China Pharmaceutical Company Recent Developments
  49. 6.9 Henan Huaxing
  50. 6.9.1 Henan Huaxing Company Information
  51. 6.9.2 Henan Huaxing Business Overview
  52. 6.9.3 Henan Huaxing Penicillin Intermediate Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Henan Huaxing Penicillin Intermediate Product Portfolio
  54. 6.9.5 Henan Huaxing Recent Developments
  55. 6.10 Harbin Pharmaceutical Group
  56. 6.10.1 Harbin Pharmaceutical Group Company Information
  57. 6.10.2 Harbin Pharmaceutical Group Business Overview
  58. 6.10.3 Harbin Pharmaceutical Group Penicillin Intermediate Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Harbin Pharmaceutical Group Penicillin Intermediate Product Portfolio
  60. 6.10.5 Harbin Pharmaceutical Group Recent Developments
  61. 6.11 Shanghai Shyndec Pharmaceutical
  62. 6.11.1 Shanghai Shyndec Pharmaceutical Company Information
  63. 6.11.2 Shanghai Shyndec Pharmaceutical Business Overview
  64. 6.11.3 Shanghai Shyndec Pharmaceutical Penicillin Intermediate Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Shanghai Shyndec Pharmaceutical Penicillin Intermediate Product Portfolio
  66. 6.11.5 Shanghai Shyndec Pharmaceutical Recent Developments
  67. 6.12 Fuan Pharmaceutical group
  68. 6.12.1 Fuan Pharmaceutical group Company Information
  69. 6.12.2 Fuan Pharmaceutical group Business Overview
  70. 6.12.3 Fuan Pharmaceutical group Penicillin Intermediate Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Fuan Pharmaceutical group Penicillin Intermediate Product Portfolio
  72. 6.12.5 Fuan Pharmaceutical group Recent Developments
  73. 6.13 Yili Chuanning Biotechnology
  74. 6.13.1 Yili Chuanning Biotechnology Company Information
  75. 6.13.2 Yili Chuanning Biotechnology Business Overview
  76. 6.13.3 Yili Chuanning Biotechnology Penicillin Intermediate Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Yili Chuanning Biotechnology Penicillin Intermediate Product Portfolio
  78. 6.13.5 Yili Chuanning Biotechnology Recent Developments
  79. 6.14 Changzhou RedSun
  80. 6.14.1 Changzhou RedSun Company Information
  81. 6.14.2 Changzhou RedSun Business Overview
  82. 6.14.3 Changzhou RedSun Penicillin Intermediate Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Changzhou RedSun Penicillin Intermediate Product Portfolio
  84. 6.14.5 Changzhou RedSun Recent Developments
  85. 6.15 Centrient Pharmaceuticals
  86. 6.15.1 Centrient Pharmaceuticals Company Information
  87. 6.15.2 Centrient Pharmaceuticals Business Overview
  88. 6.15.3 Centrient Pharmaceuticals Penicillin Intermediate Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Centrient Pharmaceuticals Penicillin Intermediate Product Portfolio
  90. 6.15.5 Centrient Pharmaceuticals Recent Developments
  91. 6.16 XINXIANG BEST PHARMACEUTICAL
  92. 6.16.1 XINXIANG BEST PHARMACEUTICAL Company Information
  93. 6.16.2 XINXIANG BEST PHARMACEUTICAL Business Overview
  94. 6.16.3 XINXIANG BEST PHARMACEUTICAL Penicillin Intermediate Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 XINXIANG BEST PHARMACEUTICAL Penicillin Intermediate Product Portfolio
  96. 6.16.5 XINXIANG BEST PHARMACEUTICAL Recent Developments
  97. 6.17 United Laboratories
  98. 6.17.1 United Laboratories Company Information
  99. 6.17.2 United Laboratories Business Overview
  100. 6.17.3 United Laboratories Penicillin Intermediate Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 United Laboratories Penicillin Intermediate Product Portfolio
  102. 6.17.5 United Laboratories Recent Developments
  103. 6.18 TUL
  104. 6.18.1 TUL Company Information
  105. 6.18.2 TUL Business Overview
  106. 6.18.3 TUL Penicillin Intermediate Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 TUL Penicillin Intermediate Product Portfolio
  108. 6.18.5 TUL Recent Developments
  109. 6.19 Sinopharm Weiqida Pharmaceutical
  110. 6.19.1 Sinopharm Weiqida Pharmaceutical Company Information
  111. 6.19.2 Sinopharm Weiqida Pharmaceutical Business Overview
  112. 6.19.3 Sinopharm Weiqida Pharmaceutical Penicillin Intermediate Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Sinopharm Weiqida Pharmaceutical Penicillin Intermediate Product Portfolio
  114. 6.19.5 Sinopharm Weiqida Pharmaceutical Recent Developments
  115. 6.20 Sichuan Huaxin
  116. 6.20.1 Sichuan Huaxin Company Information
  117. 6.20.2 Sichuan Huaxin Business Overview
  118. 6.20.3 Sichuan Huaxin Penicillin Intermediate Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Sichuan Huaxin Penicillin Intermediate Product Portfolio
  120. 6.20.5 Sichuan Huaxin Recent Developments
  121. 6.21 Qilu Tianhe Pharma
  122. 6.21.1 Qilu Tianhe Pharma Company Information
  123. 6.21.2 Qilu Tianhe Pharma Business Overview
  124. 6.21.3 Qilu Tianhe Pharma Penicillin Intermediate Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 Qilu Tianhe Pharma Penicillin Intermediate Product Portfolio
  126. 6.21.5 Qilu Tianhe Pharma Recent Developments
  127. 6.22 Novartis Sandoz Anti-Infectives
  128. 6.22.1 Novartis Sandoz Anti-Infectives Company Information
  129. 6.22.2 Novartis Sandoz Anti-Infectives Business Overview
  130. 6.22.3 Novartis Sandoz Anti-Infectives Penicillin Intermediate Sales, Revenue and Gross Margin (2021-2026)
  131. 6.22.4 Novartis Sandoz Anti-Infectives Penicillin Intermediate Product Portfolio
  132. 6.22.5 Novartis Sandoz Anti-Infectives Recent Developments
  133. 6.23 LKPC
  134. 6.23.1 LKPC Company Information
  135. 6.23.2 LKPC Business Overview
  136. 6.23.3 LKPC Penicillin Intermediate Sales, Revenue and Gross Margin (2021-2026)
  137. 6.23.4 LKPC Penicillin Intermediate Product Portfolio
  138. 6.23.5 LKPC Recent Developments
  139. 6.24 Kelun
  140. 6.24.1 Kelun Company Information
  141. 6.24.2 Kelun Business Overview
  142. 6.24.3 Kelun Penicillin Intermediate Sales, Revenue and Gross Margin (2021-2026)
  143. 6.24.4 Kelun Penicillin Intermediate Product Portfolio
  144. 6.24.5 Kelun Recent Developments
  145. 6.25 Jiangxi Fushine Pharmaceutical
  146. 6.25.1 Jiangxi Fushine Pharmaceutical Company Information
  147. 6.25.2 Jiangxi Fushine Pharmaceutical Business Overview
  148. 6.25.3 Jiangxi Fushine Pharmaceutical Penicillin Intermediate Sales, Revenue and Gross Margin (2021-2026)
  149. 6.25.4 Jiangxi Fushine Pharmaceutical Penicillin Intermediate Product Portfolio
  150. 6.25.5 Jiangxi Fushine Pharmaceutical Recent Developments
  151. 6.26 Huayao Group
  152. 6.26.1 Huayao Group Company Information
  153. 6.26.2 Huayao Group Business Overview
  154. 6.26.3 Huayao Group Penicillin Intermediate Sales, Revenue and Gross Margin (2021-2026)
  155. 6.26.4 Huayao Group Penicillin Intermediate Product Portfolio
  156. 6.26.5 Huayao Group Recent Developments
  157. 6.27 Hayao
  158. 6.27.1 Hayao Company Information
  159. 6.27.2 Hayao Business Overview
  160. 6.27.3 Hayao Penicillin Intermediate Sales, Revenue and Gross Margin (2021-2026)
  161. 6.27.4 Hayao Penicillin Intermediate Product Portfolio
  162. 6.27.5 Hayao Recent Developments
  163. 6.28 E-Cspc
  164. 6.28.1 E-Cspc Company Information
  165. 6.28.2 E-Cspc Business Overview
  166. 6.28.3 E-Cspc Penicillin Intermediate Sales, Revenue and Gross Margin (2021-2026)
  167. 6.28.4 E-Cspc Penicillin Intermediate Product Portfolio
  168. 6.28.5 E-Cspc Recent Developments
  169. 6.29 CSPC Zhongrun
  170. 6.29.1 CSPC Zhongrun Company Information
  171. 6.29.2 CSPC Zhongrun Business Overview
  172. 6.29.3 CSPC Zhongrun Penicillin Intermediate Sales, Revenue and Gross Margin (2021-2026)
  173. 6.29.4 CSPC Zhongrun Penicillin Intermediate Product Portfolio
  174. 6.29.5 CSPC Zhongrun Recent Developments
7 North America by Country
  1. 7.1 North America Penicillin Intermediate Sales by Country
  2. 7.1.1 North America Penicillin Intermediate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Penicillin Intermediate Sales by Country (2021-2026)
  4. 7.1.3 North America Penicillin Intermediate Sales Forecast by Country (2027-2032)
  5. 7.2 North America Penicillin Intermediate Market Size by Country
  6. 7.2.1 North America Penicillin Intermediate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Penicillin Intermediate Market Size by Country (2021-2026)
  8. 7.2.3 North America Penicillin Intermediate Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Penicillin Intermediate Sales by Country
  2. 8.1.1 Europe Penicillin Intermediate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Penicillin Intermediate Sales by Country (2021-2026)
  4. 8.1.3 Europe Penicillin Intermediate Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Penicillin Intermediate Market Size by Country
  6. 8.2.1 Europe Penicillin Intermediate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Penicillin Intermediate Market Size by Country (2021-2026)
  8. 8.2.3 Europe Penicillin Intermediate Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Penicillin Intermediate Sales by Country
  2. 9.1.1 Asia-Pacific Penicillin Intermediate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Penicillin Intermediate Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Penicillin Intermediate Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Penicillin Intermediate Market Size by Country
  6. 9.2.1 Asia-Pacific Penicillin Intermediate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Penicillin Intermediate Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Penicillin Intermediate Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Penicillin Intermediate Sales by Country
  2. 10.1.1 South America Penicillin Intermediate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Penicillin Intermediate Sales by Country (2021-2026)
  4. 10.1.3 South America Penicillin Intermediate Sales Forecast by Country (2027-2032)
  5. 10.2 South America Penicillin Intermediate Market Size by Country
  6. 10.2.1 South America Penicillin Intermediate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Penicillin Intermediate Market Size by Country (2021-2026)
  8. 10.2.3 South America Penicillin Intermediate Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Penicillin Intermediate Sales by Country
  2. 11.1.1 Middle East and Africa Penicillin Intermediate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Penicillin Intermediate Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Penicillin Intermediate Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Penicillin Intermediate Market Size by Country
  6. 11.2.1 Middle East and Africa Penicillin Intermediate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Penicillin Intermediate Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Penicillin Intermediate Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Penicillin Intermediate Value Chain Analysis
  2. 12.1.1 Penicillin Intermediate Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Penicillin Intermediate Production Mode & Process
  7. 12.2 Penicillin Intermediate Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Penicillin Intermediate Distributors
  10. 12.2.3 Penicillin Intermediate Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst